4Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002,100:2292-2302.
5Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982,51 : 189-199.
6Greenberg P, Cox C, LeBeau MM, et al. International scoring systerm for evaluating prognosis in myelodysplastic syndromes. Blood, 1997,89:2079-2088.
7Bowen D, Gulligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of aduh myelodysplastic syndromes. Br J Heamatol, 2003,120 : 187-200.
8Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res,2007,31:727-736.
9Shi J, Shao Z, Chen G, et al. Clinical and laboratory features of preleukemia patients. Chin Med J(Engl) ,2002,115:3-7.
10Vardiman JW, Harris NL, Brunning RD. The World Health Organization(WHO) classification of the myeloid neoplasms[J]. B/ood,2002, 100 ( 7 ) :2292 - 2302.
